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Abstract: Early detection and diagnosis is a must in secondary prevention of melanoma
and other cancerous lesions of the skin. In this work, we present an online, reservoir-based,
non-parametric estimation and classification model that allows for this functionality on pigmented
lesions, such that detection thresholding can be tuned to maximize accuracy and/or minimize
overall false negative rates. This system has been tested in a dataset consisting of 116 patients
and a total of 124 hyperspectral images of nevi, raised nevi and melanomas, detecting up to 100%
of the suspicious lesions at the expense of some false positives.
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Although it only constitutes about 1–5% of total cancer cases –depending on the country–,
melanoma is the deadliest form of skin cancer known to date. It accounts for at least two thirds
of all skin cancer-related deaths in the US [1], and its incidence over time has also increased; for
instance, it has duplicated since the 1990s (up to 128%) in the UK [2]. As a consequence of
its incidence and mortality, there are numerous campaigns encouraging primary prevention, as
well as increased costs in secondary prevention –also known as early detection– and treatment
interventions. For example, yearly estimates of the cost of melanoma care currently hold at about
$44.9 million dollars for already existing cases, and circa $932.5 million dollars for new cases
across all age groups in the US Medicare system alone [3].
Current detection and early diagnosis methods are mainly clinical inspection, followed by
histopatological diagnosis of the extracted lesion if the pathologist suspects malignancy. Human
error has been reported to be up to 15% among experts when coming to diagnose a lesion
as cancerous [4]. Therefore, it is key to devise reliable, automated screening procedures that
minimize false negatives as a first priority, and –secondarily– minimize the number of false
positives, if possible. It would also be ideal if early screening methods could be set in non-
specialized clinics, therefore avoiding cluttering of dermatology wards with unsuspicious lesions,
and providing experts with clinically difficult cases. In such a scenario, automated primary care
screening could become just as reliable as skin self-examination (SSE) practices –which are
still not prevalent among the general population– while also minimizing time spent by general
practice physicians on whole-body skin examination (PSE) [5, 6].
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The field of Applied Photonics (a key enabling technology (KET) as defined by the High-
Level Expert Group of KETs of the European Commision [7]), has proven itself capable of
minimizing both problematics. In particular, hyperspectral imaging (HSI) has shown promise
for the detection of malignant lesions, given the rich chromophore-related information provided
by radiation backscattered from tissues. Macroscopic HSI has been thoroughly employed
in tissue classification [8–13], lesion segmentation [14, 15], and quantification of detectable
chromophores [16,17], among others (for further discussion on the capabilities of HSI as a clinical
technique, please refer to reviews [17], [18], [19] and [20]). In the field of dermatology, multi-
spectral digital skin lesion analysis (MSDSLA) devices are capable of detecting inflammation [21],
segmenting and differentiating between malignant and benign melanocytic and non-melanocytic
lesions [22–29]. Chromophores present in melanocytic lesions have been evaluated in large
spectroscopic studies as well [30]. Assisted diagnosis has already been tested for multispectral
images in commercially available systems such as SiaScope or MelaFind, with improvements in
sensitivity and specificity in the range of 5-10% [20,31] and biopsy sensitivity and accuracy of
up to 20% (from 64% to 86%) when used complementarily with standard clinical dermatology
practice [32].
Most diagnosticmethods inHSI imaging usewell-known, standardmachine learning algorithms,
such as Support Vector Machines (SVMs), deep neural networks (both convolutional and
feedforward), a combination of dimensionality reduction by Principal Component Analysis (PCA)
and a clustering/classification algorithm (i.e. k-means, k-nearest neighbors), plain correlation [19],
or a combination of these methods [33]. Unfortunately, algorithms that perform dimensionality
reduction –such as PCA or the Singular Value Decomposition (SVD)– struggle with large datasets
due to the computational complexity of the SVD. Neural networks and SVMs, on the other
hand, rely on obtaining a hidden function that translates the problem domain into the solution
domain by means of optimization, achieving classification. These two issues –i.e., the quadratic
complexity of dimensionality reduction algorithms with respect to dataset size and being unable
to easily determine the proper significance and clinical exploitability of any automated diagnosis–
could complicate the usability of these methods in secondary prevention, and therefore should be
avoided. Also, the advent of new MSDSLA systems in recent years call for a simple, concise
detection protocol that allows the use of any molecular imaging system to assist in a clinical
setting [32].
In this work, we describe and test an algorithm capable of dealing with large lesion datasets,
reducing dimensionality while taking into account all incoming samples, and obtaining a
metric or function that has a transparent, simple relationship between any pathology and its
signature features, while also allowing for the classification of any additional lesions quickly and
accurately, following a specified clinical policy. This combination of well-known algorithms is
based on the Neyman-Pearson Lemma –the basis of the classical radar detection problem– and,
given its constitutive elements, can be described as a reservoir-based, online, multidimensional
non-parametric probability density estimation and classification framework on large datasets.
The proposed approach on the classification problem begins with finding a vector basis that can
explain the dataset as a whole and reduce its dimensionality so that, through random population
subsampling, it is possible to obtain statistically significant populations for each particular
pathology under study, large enough to adequately interpolate the probability density function
(PDF) of each tissue category in the low-dimensional, newly found feature space. Said PDFs are
obtained and used to specify the most likely features or spectral signatures of each particular
pathology. The interpolation –or, rather, estimate– of the PDF is calculated with kernel density
estimation (KDE), and a Likelihood Ratio Λ(x) and threshold parameter γ are established in
such a way that detection is maximized. This PDF estimate is evaluated, then, on incoming new
pixels, and the likelihood ratio is employed in their classification. Different applications have
validated the feasibility of KDE for segmentation, in the fields of home range analysis [34], visual
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surveillance systems [35] as well as hyperspectral remote sensing [36] and ship detection via
synthetic aperture radar [37].
The combined action of population subsampling and density estimation of each population
allows for the classification of hyperspectral images with tunable sensitivity and specificity, as
the problem requires. In our case, we wish to either minimize false negatives at the expense of a
few false positives (to minimize misdetection) or maximize overall accuracy.
2. Materials and methods
2.1. The melanoma HSI dataset
In order to test the proposed methodology, we require a multispectral dataset of pigmented
lesions. The selected hyperspectral database was generated by Spigulis, Lihacova (formely
Diebele), Kuzmina et al. during several clinical trials in a collaboration between the Biophotonics
Laboratory of the Institute of Atomic Physics and Spectroscopy and several clinics in Riga,
Latvia [22, 23, 38, 39]. This dataset consists of 116 patients (52 nevi patents, 33 raised nevi
patients, 31 melanoma patients). In some nevi and raised nevi patients, more than one lesion has
been imaged. The total number of samples is 124 (59 nevi, 35 raised nevi, and 31 melanomas).
Table 1 describes the number of patients and number of lesions imaged per patient. There are
no patients with more than one type of lesion (i.e. patients with benign and malignant lesions
simultaneously).
For every patient, a concise protocol was followed, for which about 30 minutes were required
per lesion, of which up to 2 minutes were used for long-exposure acquisition [22]. Nevi were
inspected by dermatologists, whereas melanomas also underwent histological examination to
prove their malignancy, as usual in these types of clinical studies [31, 40].








Nevus 45 7 59
Raised nevus 31 2 35
Melanoma 31 0 31
Total 116 patients 124 samples
The images vary in spatial resolution, but are consistent in spectral resolution per pixel. The
device utilized was a 51-channel, 16-bit Nuance EX hyperspectral camera, which operates
in the Vis-NIR range (450–950 nm), with a step of 10 nm. Optical density, OD, was directly
calculated by Nuance software as a function of reflectance R(λ) via the well-known equation





= − log10 (R(λ)) , (1)
with I(λ) the received light intensity at the sample, and I0(λ) a reference spectrum, in particular
a sheet of paper applied over the lesion [41]. The white reference image defines the exposure
time required to maximize dynamic range in the hyperspectral system. That same exposure time
is then used on the lesion itself [22].
Given the fact that there were no regions of interest (ROIs) in the dataset itself, two rectangular
regions of interest were generated manually for each specimen, such that –for each of the samples–
one ROI was placed within the melanocytic lesion, and the other in a surrounding area, where
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there is visibly no lesion present. These ROIs (in-lesion and out-of-lesion) do not intend to
provide clinical nor spatial information, as they just serve as locations for our method to extract
spectra from within and outside each pigmented lesion. Special care was taken in order to keep
the ROIs as clean and far away from fringe regions as possible. Also, in order to avoid any
classification performance biases, we will evaluate the algorithm on a patient-by-patient basis,
instead of analyzing samples separately, mimicking as realistically as possible what would happen
in a real clinical setting.
2.2. Standard normal variate (SNV)
Interpatient –or intersubject– variability, i.e. the inconsistency in measurement characteristics
amongst subjects that should a posteriori be classified as identical [42], is a prevalent phenomenon
in fields such as hyperspectral imaging. Changes in position and illumination make non-contact
diagnosis of material properties notably difficult in many cases [43]. In order to compensate for
this variation, we chose to employ the standard normal variate (SNV), known for eliminating
bias and trend in spectra [44]. In obtaining the SNV, each reflectance vector x ∈ Rn will be
converted into a normalized vector x ′, by means of subtracting its average value µ = 1N
∑N
i=1 xi





2.3. Sequential singular value decomposition (SVD)
Consider a corrected hyperspectral matrix as a tensor A ∈ Rm×n×l with real elements {amnl} =
R(m∆x, n∆y, λ0 + l∆λ) representing the diffuse surface reflectance of the material under test
at discrete positions (m∆x, n∆y) and wavelengths λ0 + l∆λ (with ∆x,∆y,∆λ the spatial and
spectral resolutions established by the system, respectively), and A = A(3) ∈ Rl×mn as its mode-l
matrization, such that each column in A represents the spectrum of a single pixel. In other words,
if we ignore pixel position and only pay attention to its spectral characteristics, the singular value
decomposition
A = UΣVT (3)
allows the representation of A as a sum of matrices of rank one




with r = rank(A) the rank of our matrix, u1, . . . , ur the left singular vectors of A (columns of
orthogonal matrix U), σ1, . . . , σr its singular values (nonzero elements in diagonal matrix Σ),
and v1, . . . , vr its right singular vectors (columns of orthogonal matrix V). This means that the
SVD allows for lossy compression of spectra (i.e. dimensionality reduction) by means of an
L-rank approximation, accomplished by truncating the sum in Equation (4). The error of this
approximation is known; it is given by the next singular value, such that if ÃL = E1 + · · · + EL ,
L ≤ r , then
‖A − ÃL ‖F ≤ σL+1
will hold true for any A [45]. Thus, if there is notable redundancy in the columns of A, it will be
possible to represent each column at as a weighted sum of the first L  r columns of U, namely






ui 〈ui, at〉, (5)
where 〈., .〉 represents the inner product of any two column vectors. The coefficients αt,1, . . . , αt,L
are the coordinates of the t-th column vector of A in the space described by the first L vectors of
U in Equation (3).
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Finding the basis for a single image is not a problem from a practical perspective; the total
number of operations required for executing the SVD on a matrix A ∈ RM×N is O(MN2), while
using O(MN) memory. These algorithms, though, become problematic as the number of column
vectors N increases, which is something that is expected to happen when dealing with large
datasets. That, and the fact that we are looking for an L-rank approximation with a very small L,
calls for an algorithm that efficiently calculates the first few singular vectors of a matrix composed
by concatenated matrices A = (A1 |A2 | . . . ) by analyzing each matrix separately.
The sequential Karhunen-Loeve (SKL) algorithm, which is based on the R-SVD algorithm,
can be of good use for this purpose. Given a matrix A ∈ RM×N , the SKL algorithm obtains
–by taking the columns of A in batches of P columns– the first K columns of U in Equation (3)
with negligible errors, in O(MNK) operations and using O(MK) space [46]. Thus, using an
implementation of the SKL algorithm, and by specifying a value of K sufficiently large such that
L fulfills K > L, but also K, P  N1 + N2 + . . . , it is possible to find the first K columns of U
that can represent a complete dataset in a feasible manner.
Once we have a vector basis of size K , we may choose L by looking at the relative contribution
(singular-value-wise) of each additional dimension to the trace of Σ (and, thus, the quality of the
approximation). Instead of selecting a fixed value of L, once the SKL algorithm has provided us














becomes negligible, e.g. where σcontrib ≤ 10−3, which is a common dynamic threshold for
dimensionality reduction [10, 14].
A projection of each spectrum at in the newly found feature space given by u1, . . . , uL as in
Equation (5) provides us with xt = (αt,1, . . . , αt,L)T which will correspond to the coordinates of
spectrum at in a feature vector space of reduced dimensionality that explains with high fidelity
most of the properties of all tissue samples in the dataset. This vector basis will be obtained from
the ROIs specified in the previous section.
2.4. Kernel density estimation
After each spectrum is located in a vector space common to all subjects, the next step is to assume
that each pixel xt is a sample from an n-dimensional random variable X , which is assumed to
have a different response to each given diagnostic hypothesis X |H0, . . . , X |Hm, where m is the
number of hypotheses. Specifically, this work evaluates 3 different hypotheses: H0 for nevus; H1
for melanoma and H2 for healthy skin.
Ideally, we seek to obtain the probability density function of this variable given each hypothesis,
namely f (x |H0), . . . , f (x |Hm). In other words, f (x |H1) represents the value of the likelihood of
x ∈ RL belonging to a specific hypothesis or tissue type, in this case H1, melanoma. If we are
given a sample set of n pixels given the k-th hypothesis, X |Hk , i.e. Xk,1, . . . , Xk,n, the probability
density function (PDF) f (x |Hk) at position x can be estimated using a multivariate kernel density
estimator [47]:





K(x − Xk,i), (7)
and here K(.) is referred to as the kernel function. Since the reference vectors are more determinant
than the kernel function in terms of accuracy, we use the standard multivariate normal kernel
K(x) = (2π)−d/2 |H |−1/2e− 12 xT H−1x, (8)
and here d is the dimension of the vector space and H is the bandwidth matrix. For our system,
Silverman’s rule-of-thumb estimator was used [47], which gives the optimal window with for
                                                                      Vol. 9, No. 12 | 1 Dec 2018 | BIOMEDICAL OPTICS EXPRESS 6287 
the smoothing of normally distributed data with variance σi on each dimension, and so H is a










d+4 , i = j,
0, i , j,
(9)
and, since our dimension is given by the SKL algorithm, d = L.
2.5. C++ KDE implementation
Since kernel density estimation requires a total of n operations per reservoir (given by Equation
(7)), KDE was implemented in C++ with hardware acceleration libraries, in order to reduce
overall execution runtime. For this implementation, both the GSL (GNU Scientific Library) and
the OpenCL (Open Computing Language) GPU (Graphics Processing Unit) APIs (Application
Programming Interfaces) were used.
Verification of estimation accuracy was performed by comparing the numerical differences
between the results given by the hardware-accelerated implementation and other high-level
language implementations (Python 3 and MATLAB) on random RGB images, using a computer
with an Intel i7 6700 processor (8-core, 3.4 GHz GPU) and an nVidia GeForce
GTX 1060 (3GB RAM) graphics card.
As a result of hardware acceleration, it was possible to obtain an average speedup factor of
45×, and a negligible average relative numerical error in the order of 10−7 percent. A secondary
test was carried out where CPU (Central Processing Unit) multithreading was used, obtaining a
5× speedup on average. The GPU-accelerated method was selected as preferable and wrapped
accordingly for its use with the other Python3-implemented functions, which allowed us to
generate PDF estimates of whole images in the order of milliseconds.
2.6. Reservoir sampling and Algorithm R
For a set of q pixels under analysis, and n reference pixels for each hypothesis, the number of
operations specified in Equation (7) are in the order of qn products of vectors of dimension d. As
the resolution of the image and/or the number of reference pixels increases, the operation becomes
unfeasibly large, and so we must reduce either quantity, even when recurring to parallelization.
Random sampling –the selection without replacement of a random sample of size n from a
pool of N  n entries– is useful in this context. A reservoir is just the result of performing
random sampling: given a complete set of samples S, |S | = N , a reservoir is a subset R ⊂ S with
size |R| = n. The main property of an adequate reservoir is that the probability of any vector in
the pool to belonging to the reservoir is a constant, namely P(s ∈ R) = n/N, ∀s ∈ S.
There are several algorithms that allow this with more or less optimality, but for our case
the simplest (Algorithm R) was employed, due to current processor speeds and random number
generation not being the bottleneck of the system. In Algorithm R, the reservoir R is initialized
with the first n entries of S (i.e. R = {s1, . . . , sn}) and then the next n + 1, . . . , N entries are read
consecutively. For each entry st, t ∈ [n + 1, N] in S, we obtain a single sample of i, an integer,
uniformly distributed random variable in the interval [1, t]. The i-th entry in R is substituted by
st if i < n. By following this procedure, all the elements in S are read only once, enabling us to
continue with an online approach [48].
2.7. Naïve Bayesian and weighted one-versus-all (OVA) classification
Given a newly acquired spectrum xt ∈ RL for which probability density function estimates for
each tissue type f (xt |H1), f (xt |H2), . . . , f (xt |Hm) have been calculated, we may proceed by
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classifying such position by a maximum a posteriori (MAP) classifier:
f (xt |Hk)P(Hk)
Hk
> f (xt |Hi)P(Hi), ∀i , k . (10)
Thus, a pixel xt is most likely to belong to class Hk if the estimated value of the likelihood
function f̃ (xt |Hk) at such position (times the a priori likelihood of the k-th hypothesis to be true)




> f (xt |Hi), ∀i , k, (11)
which is the equation corresponding to the Maximum Likelihood (ML) classifier [49]. We can
therefore use the one-versus-all (OVA) criterion for pixel classification. A pixel xt will be assiged
a class bt ∈ {H0, . . . ,Hm} by following the OVA equation
b̂t = arg max
i
{ f (xt |Hi)} , (12)
which can be weighted in order to change the probability of classification for any particular class,
by including real-valued weights γ0, . . . , γN ∈ R to the classifier:
b̂t = arg max
i
{ f (xt |Hi)γi} . (13)
For the problem at hand, γi = 1 except for the melanoma class, which will be the varying
parameter that sets, in practice, true positive and false positive rates.
2.8. Online interpatient-invariant property learning
The implementation of the reservoir-based classifier was achieved by the interconnection of
the five different functions described so far, as shown in Fig. 1. The system has two modes of
operation: sample learning and sample evaluation. We will define m as the number of classes
–hypotheses– pertaining to the problem (in our case, categories for nevi, melanoma and healthy
skin.)
During sample learning –depicted by the blue arrows in Fig. 1–, spectra-label pairs (a′t, l ′t )
are acquired in batches of size P. The SKL algorithm is then applied on the P-sized batch of
spectra, ignoring their labels. Low-dimensional feature space basis vectors u1, . . . , uK are updated
after every batch. After this calculation, each pixel in the batch is sent, without reducing its
dimensionality, into its corresponding size-n reservoir R0, . . . , Rm (depending on its label), where
algorithm R selects a subset of them randomly, generating a statistically significant population of
each class, {r0,i}, . . . , {rm,i}. Pixels that have not been randomly selected are discarded in each
reservoir.
Secondly, during sample evaluation (arrows in magenta), L < K is recalculated dynamically
by means of Equation (6). Pixels in each reservoir are projected onto the final vector basis
u1, . . . , uL calculated with SKL, obtaining the reference points for each class in the L-dimensional
vector space, {X0,i}, . . . , {Xm,i}. Once the n-sized reservoirs are represented in the updated
feature space, a new incoming pixel at can be processed. This pixel is also projected onto
the low-dimensional vector space, and its likelihood of belonging to each class is estimated
( f (xt |H0), . . . , f (xt |Hm)). Classification follows suit, using Equation (13) (or, also, the MAP/ML
classifier), obtaining its estimated tissue label l̂t .
These two steps describe, therefore, an on-line system that obtains a low-dimensional feature
space that represents features in the whole dataset and, at the same time, the most frequent
locations of these point clouds in this feature space are determined by the PDF estimates. A new
pixel is most likely to belong to the class with the highest PDF value at its position in feature
space, and therefore its assigned class will follow that rule.













































































Fig. 1. General schematic description of the workflow and modes of operation implemented
for the reservoir-based kernel density classifier. During learning (in blue) spectra-label
pairs (a′t, l ′t ) are used to update a feature space vector basis B = (u1, . . . , uL) via the SKL
algorithm and Equation (6), sorted by label and introduced into random reservoirs, where
they have a chance of staying as reference spectra {rk,i}. During evaluation (in magenta),
a new incoming spectrum at is projected onto feature space, where it is compared with
reference spectra. For that to be possible, reference spectra must also be projected onto B.
The likelihood of at belonging to each tissue type is evaluated through KDE, and a final
diagnosis l̂t is calculated.
For the results section, in order to evaluate the generalization capabilities of this method, we
have enforced different approaches. In particular, we have evaluated our algorithm with 10-fold
and 3-fold cross-validation, as well as leave-one-out cross-validation (LOOCV). In all cases, we
seek to learn from patients instead of separate samples, in order to avoid biasing our algorithm
with a priori information. Diagnoses are accounted in a per-sample basis in order to simulate a
realistic clinical setting.
In leave-one-out cross-validation, for each of the 116 patients, reservoirs were emptied, SKL
was reset to its initial condition, and sample acquisition was performed with the other 115 patients.
Then, evaluation was performed on the patient under test, as if it were a new incoming patient
that the system had not seen before. Its samples are evaluated separately and their diagnosis
are tallied on the confusion matrix. Threshold parameters γ0, . . . , γm are to be evaluated as a
function of its effect on the Receiver Operating Characteristic (ROC). A similar approach is
enforced for 3-fold and 10-fold cross-validation.
3. Results and discussion
3.1. Dimensionality reduction and vector basis
The first step in our process is the on-line extraction of a low-dimensional feature space. We must
study the characteristics of the basis that describes such space, as well as how many dimensions
are necessary to explain most of the features in it. The first five left-singular vectors that conform
the space for the HSI melanoma dataset, as well as the cumulative sum of the square of the
singular values of Σ in the SVD, are shown in Fig. 2. The first three basis vectors in feature
space (those that represent an absorption peak around 550 nm and a slope in the red and infrared
wavelengths) are the best feature descriptors for the problem at hand.
Although these feature basis vectors do not represent any isolated physical characteristics for
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Fig. 2. First five left singular vectors, namely u1, . . . , u5, of the HSI melanoma feature space
(left) and cumulative sum of explained variance (square of singular values).
the dataset, a change in slope in the 600-900 nm range characteristic of melanin, and the typical
absorption peaks of hemoglobin around 530-600 nm can be seen [17, 22]. It must also be noted
that, since the SVD is a deterministic operation, the results and ordering of these feature vectors
will be a result of the amount of data processed so far. These events are, therefore, the most
repeated occurrences in all observed tissue spectra [45].
The low dimensionality required to represent melanocytic lesion spectra, as shown in the
right subplot of Fig. 2, must be commented as well. Applying Equation (6) provides us with
an L in the range of 3 to 10, depending on the degree of explained variance desired. For the
aforementioned σcontrib ≤ 10−3 criterion, L stays in the range L < 11. This confirms the fact
that most of our data lies in a feature space of low dimensionality, as is common in hyperspectral
images of biological tissues, and that using more dimensions will not benefit estimation nor
classification significantly [9, 14]. Figure 3 represents the positions in feature space of 4000
points per pathology, selected via Algorithm R in three distinct reservoirs, and pre-processed by
the Standard Normal Variate algorithm (hence, laying on an L-dimensional sphere).
Fig. 3. Data clouds of the dataset in the basis defined by u1, u2 and u3 (4000-point reservoir
per category). The scatter plots are 2D and they display (a) the first two dimensions in
feature space, (b) the second and third dimensions in feature space, and (c) the third and first
dimensions in feature space, as given by their coordinates (α1, α2, α3). The data lay in an
L-dimensional sphere due to the Standard Normal Variate.
In order to test the validity of our ROIs, we should at least compare the average spectra of each
pathology with other state-of-the-art studies. Figure 4 displays the average spectra and standard
deviation of nevi, melanoma and healthy skin, respectively. Average reflectance as well as
standard deviations for each of the pathologies are within range of what has been shown in larger
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clinical trials [28, 30] and in the articles that explain how the dataset was obtained [22, 38, 41].
A few things can be noted about the spectra. Melanoma spectra are notably different in
both shape and absorption in certain wavelengths. The presence of melanin can be seen in the
600–700 nm range, whereas healthy skin shows lower absorption and variance. Note also the
lack of absorption in the 400–500 nanometer range in melanoma, perhaps due to blue-white veil
present in the images, as well as different concentrations of oxy- and deoxyhemoglobin [17].
Note, though, that the variability of melanoma –as shown by the scatter plots of Fig. 3– is
more significant, and thus evaluating spectra with every spectrum in the dataset or with the
average spectrum of melanoma turns practically unfeasible and prone to misdiagnosis. This
can be explained by the fact that there will be non-cancerous spectra in feature space closer to
the average spectrum of melanoma than to the average spectrum of nevi, and viceversa. Such
a result suggests that estimating likelihood and class probability metrics in feature space will
certainly provide a similarity function that holds true across all cases consequence of interpatient
variability.








































































Fig. 4. Average values (solid line) and standard deviation (shaded regions) of spectra within
reservoirs of size 4000 for each tissue class considered: nevi (left), melanoma (center) and
healthy skin (right).
3.2. Segmentation and qualitative results
If we wish to diagnose a lesion by tissue type ratios, we must ensure lesion segmentation works
in all the samples. We have chosen leave-one-out cross-validation as a first approach. For a given
patient, every sample in the dataset except that patient was used to estimate the PDF function
of each tissue type in feature space. Every pixel in each image will have a location in feature
space, and therefore will be assigned a tissue class with weighted OVA (depending on the weights
shown in Equation (13)).
From now on, we will consider three tissue types or hypotheses: the Nevus,Melanoma and
Skin classes will be referred to as H0, H1, and H2, respectively (skin-lesion segmentation must
be performed automatically, hence why a ’Healthy Skin’ reservoir is also considered). For a
given sample, the PDF or likelihood values f (x |H0), f (x |H1) and f (x |H2) can be calculated for
each pixel. As shown in Equation (13), for classification there is an associated weight for each
tissue class, namely γ0 for Nevus, γ1 for Melanoma and γ2 for Skin spectra. This constitutes a
three-parameter system with two degrees of freedom: that given by γ1 in relation to γ0 will allow
us to compare benign with malignant melanocytic spectra, and that given by γ2 with respect to
any pigmented spectra (γ1 and γ0) will provide segmentation.
Since skin pigmentation will be dependent on patient skin fairness, we have chosen a dynamic
version of the elbow method [50]. We shall begin with the maximum likelihood scenario, where
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∈ [0, 1], (14)
where Nles is the number of pixels classified as pigmented spectra (Nevus or Melanoma) that are
obtained with Equation (13), and Ntotal is the total number of pixels in the image. This ratio can
take any value between 0 and 1, with ρ = 1 meaning all pixels are considered pigmented and
ρ = 0 meaning no pixels in the image are pigmented. As γ2 increases, more skin spectra will
be classified as skin. The ratio will decrease up to a point of saturation, where ρ stabilizes for
a finite interval of γ2 and the lesion remains classified as such, and afterwards more and more
pixels in the lesion are classified as skin until ρ = 0 and the lesion ROI vanishes. Similarly to the
dynamic thresholding in Equation (6), we can calculate the finite-difference approximation of the
second derivative of ρ with respect to γ2. As shown in Fig. 5, the second derivative of ρ(γ2),
ρ′′(γ2), relates with the variation of its curvature. If the maximum value of ρ′′(γ2) indicates
where the elbow is, then stabilization will take place after the elbow, once ρ′′ tends to zero again.
Therefore, we can choose a relative dynamic threshold, such that the optimal segmentation value,









and thus finding the end of the elbow in ρ(γ2). Here, ρ′′max is the maximum of the second
derivative. In other words, we choose a value for γ2 where the curvature of the size of the lesion
stabilizes up to 1/100 of its maximum variation. Since numerical variables usually have noisy
values, ρ′′(γ2) has been stabilized with a Savitzky-Golay filter (window size 11, order 7). This
procedure is followed analogously in n-fold cross-validation.






























Segmentation at ML solution
Nevus
HealthySkin
Fig. 5. Elbow method segmentation example for Patient 2, Sample 2. On the left plot, values
of ρ, (in blue), its derivative (in green and black) and the elbow point chosen by the criterion
in Equation (15). The center and right subplots show the segmentation given by the elbow
method and standard maximum likelihood classification (i.e. γ0 = γ1 = γ2), respectively.
Once segmentation is achieved, in-lesion classification just requires separating pigmented
pixels with their PDF values. Figures 6 and 7 are two examples of the results provided by the
system. The SKL subroutine was defined with batch size P = 200, forget factor f = 1, and
ε = 10−5. Reservoir size was 4000 per spectral class. Each figure contains an RGB reconstruction
of the absorption spectra, using the CIE 1931 color matching functions (CMFs) and considering
a D65 illuminant [51]. The final classification/segmentation results are shown in the right-side
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subplots of the first row of each example. Segmentation behaves generally well, for as long as
there are no hairs in the image (hair has some degree of brown pigmentation, and is sometimes
indistinguishable from with melanocytic tissue spectra). Note that this segmentation is obtained
by directly comparing the three subplots in the bottom row. In most nevi cases, the melanoma
hypothesis is illuminated within the melanocytic lesion, but its likelihood function is usually
ten times lower than the nevus function – something which is not the case for malignant lesions,


















































































Fig. 6. Top row. CIE 1931 RGB reconstruction of Sample 24, a nevus (left), as well as
the in-lesion and out-of-lesion ROIs (center); these ROIs aren’t used in the classification
result (shown as a semitransparent overlay on the right subplot). Bottom row. False-color
likelihood maps for the three hypotheses (from left to right, H0 : Nevus, H1 : Melanoma, and
H2 : Healthy Skin); note that each figure is complemented with a color bar with a different
scale, otherwise the likelihood map for melanoma would be too dark to see. Since the
likelihood of being melanoma is lower than the likelihood of being nevi in each pixel, they
are classified as non-malignant.
It must be noted that, given the higher variability of malignant spectra (as shown in Fig. 3),
the PDF values for the Melanoma hypothesis are lower. This is an expected result, since KDE
provides a PDF estimate and, by definition, the integral over all L-dimensional space must be
equal to one. Nevertheless, the PDF values for the other hypotheses in the regions of feature
space dominated by melanoma are zero or near zero, making the Melanoma class the dominant
spectral signature. Another characteristic that is of notable interest is the fact that the algorithm
tries –in some degree or another– to assign spectra of areas surrounding a melanoma as belonging
to the nevi class. In such fringe areas the system simply assigns pixels to the class they are
most likely to belong to, as constrained by the segmentation threshold. Given the lack of expert
ROI information, is unknown if such regions would be pigmented, non-malignant areas; further
research would be needed for a proper assesment of this response.
3.3. Diagnostic capability and ROC. Quantitative results
We will undertake now the study of the diagnostic capabilities of our algorithm, by evaluating its
Receiver Operating Characteristic (ROC) and typical binary classification parameters. In order
to describe a single sample as benign or malignant, a diagnostic rule must be established. For
this scenario, given the fact that nevi pixels are rarely classified as malignant, the defined rule
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Fig. 7. Top row. CIE 1931 RGB reconstruction of Sample 67, a melanoma (left), its
in-lesion and out-of-lesion ROIs (center) and its final classification/segmentation output as
a semitransparent overlay (right). Bottom row. False-color likelihood maps for the three
hypotheses (from left to right, H0 : Nevus, H1 : Melanoma, and H2 : Healthy Skin) for this
sample, with their accompanying color bars. The likelihood of pixels in the lesion for the
nevi and skin hypotheses is zero, and therefore most pixels within the lesion are classified as
more likely to be melanoma, while fringe regions in between skin and lesion are considered
just pigmented, due to their likelihood values in feature space.
is a diagnostic ratio, calculated as follows: given a specific sample with a lesion of size Nles
(in pixels) containing Nmal ≤ Nles pixels within the lesion classified as melanoma, it will be
diagnosed as malignant if Nmal/Nles ≥ p holds. In summary, pixels are classified following the
weighted one-vs-all method (Equation (13)), while whole-sample diagnosis is achieved with
diagnostic ratio p.
In order to test the capabilities of our system, we have evaluated classification accuracy for
3-fold and 10-fold cross-validation, as well as leave-one-out. For leave-one-out, Fig. 8 depicts
both the ROC as well as overall system accuracy as a function of γ1, swept from γ1 = 0 to
γ1 = 30, for several values of p: 0.01, 0.05, 0.1 and 0.2. As shown by this figure, the system can
achieve stable accuracies up to 95%, depending on diagnostic criterion stringency, and it behaves
like an almost-ideal radar detector. This implies, also, that lesion segmentation performs notably
well for γ0 = 1 and γ2 = 1, given the fact that diagnosis is achieved by only counting pixels
within the lesion itself. At peak performance for p = 0.05 (γ = 6.1224), the method is capable
of reaching 96.8% sensitivity, 95.7% specificity, and 96.0% accuracy. For the same diagnostic
criterion, a null false negative rate can be achieved at γ = 7.9592, with a false positive rate of
about 10%. Such a tradeoff is to be expected, as false positives will increase in number as the
false negative rate is minimized. Additional cross-validation tests can be found in Tables 2 and 3,
with p = 0.05 and maximum accuracy and minimum false negative rate criteria, respectively. We
must note that 3-fold cross-validation, due to small dataset size and reference spectra, has notably
lower (16% less) accuracy and cannot achieve zero false negatives in the range γ1 ∈ [0, 30]. This
is to be expected, but it is kept in Table 3 for the sake of comparison. As is expected as well, a
lower number of reference patients comes associated with lower accuracies, but still within range
of state-of-the-art systems [28, 32].
This figure also exhibits the change in classification performance as the diagnostic ratio
increases. As is expected, the larger the value that this ratio takes, the larger γ1 must be in order
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Receiver Operating Curve (ROC)
p = 0.01 (LOOCV)
p = 0.05 (LOOCV)
p = 0.1 (LOOCV)
p = 0.2 (LOOCV)
p = 0.0 (10-fold CV)
p = 0.01 (10-fold CV)
p = 0.05 (10-fold CV)
p = 0.1 (10-fold CV)














Accuracy as a function of γ1
p = 0.01 (LOOCV)
p = 0.05 (LOOCV)
p = 0.1 (LOOCV)
p = 0.2 (LOOCV)
p = 0.0 (10-fold CV)
p = 0.01 (10-fold CV)
p = 0.05 (10-fold CV)
p = 0.1 (10-fold CV)
Fig. 8. System Receiver Operating Characteristic (ROC, left) and total accuracy as a function
of γ1 (right), for different diagnostic ratios in leave-one-out cross-validation, namely 0.01,
























Fig. 9. Boxplot with the difference between the average f1 and f0 values inside each lesion,
f1 − f0, organized by pathology class. The difference between average class likelihoods per
sample is smaller in nevi, due to the fact that their likelihood for being melanoma f (x |H1) is
lower. This variation in likelihood functions is the key to the diagnostic capability of our
procedure.
to classify the same amount of pixels as malignant and thus reach the same diagnosis. This
relationship between γ1 and p is empirical and therefore a conservative criterion was chosen: if
a given ratio p is selected such that it contains the peak accuracy point for a value of γ1 in the
order of the other values {γi}, then that p is adequate for classification, as long as the γ1 that
maximizes accuracy can be selected. Thus, p = 0.05 was selected as an adequate diagnostic
ratio.
The diagnostic power of likelihood functions f1(x) and f0(x) can also be studied by obtaining
their average values within each lesion. Then, relationships such as d(x) = f1(x) − f0(x) or
f1/ f0 can be calculated for each lesion separately. The functions will be suitable for diagnostic
classification if they present different values per category. The average values of f1(x) and
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f0(x) per sample were obtained, their difference calculated and portrayed in a boxplot (Fig. 9).
Although the algorithm tends to provide larger values to the nevi category, d(x) presents clear
separability per tissue class by at least one full standard deviation.
Table 2. Overall system performance for different cross-validation (CV) settings (leave-one-
out, 10-fold and 3-fold) given a diagnostic ratio of p = 0.05 and maximizing for accuracy.











LOOCV 6.122 0.968 0.957 0.882 0.960
10-fold CV 7.346 0.933 ± 0.067 0.964 ± 0.054 0.944 ± 0.083 0.956 ± 0.042
3-fold CV 8.163 0.799 ± 0.141 0.927 ± 0.051 0.870 ± 0.092 0.899 ± 0.035
Table 3. Overall system performance for different cross-validation (CV) settings (leave-one-
out, 10-fold and 3-fold) given a diagnostic ratio of p = 0.05, and minimizing false negative








Precision at γ1 Accuracy atγ1
LOOCV 7.9592 1.000 0.904 0.775 0.928
10-fold CV 15.5102 1.0 ± 0.0 0.931 ± 0.054 0.869 ± 0.09 0.947 ± 0.042
3-fold CV >25.306 0.867 ± 0.094 0.871 ± 0.051 0.764 ± 0.088 0.873 ± 0.021
3.4. Performance as a function of reservoir size
It is clear, given Equation (7), that the presented methodology is highly dependent on how
good the PDF approximations are. As with all interpolation procedures, the quality of such
approximation will be a function of the number of pixels used in it. Although it has been shown
in previous work that KDE can interpolate with few pixels with notable accuracy [14], we must
study the influence of PDF estimation on overall classification performance.
For Figure 10, the effect of reservoir size on diagnostic criteria and PDF estimate fidelity was
put to the test, in the following procedure. Leave-one-out cross validation was repeated on a
fifth of the samples (i.e. Samples 1, 6, 11, 16, ..., up to Sample 116). First, ten simulations with
a reservoir size per hypothesis of 200 (as depicted by Fig. 1) obtained the PDF estimates of
each sample using leave-one-out on this reduced dataset, as in previous sections. This was then
repeated for other reservoir sizes, namely 500, 1000, 2000 and 4000.
Each of the 10 simulations provide a different PDF estimate of each sample. For the leftmost
subplot of Fig. 10, we calculated the variance in average PDF value among the 10 simulations in
each pixel, then calculated and then averaged for all pixels and all 25 samples. Such procedure is
then repeated for all the other reservoir sizes. This provides us a proof that the PDF estimates,
although obtained by means of a random reservoir, will vary on average in the order of 10−4 for
benign tissue and 10−8 for malignant tissue, depending on the reference pixels used, which is
rather negligible (< 1%) for PDF estimate values in the range [0.02, 2].
All 10 PDF estimates per sample are then classified following the accuracy-maximization
criterion –weighted one-versus-all, γ1 = 6.114, p = 0.05 (5%)–. Segmentation parameters were
kept as specified in Section 3.2. For each simulation we classified, as indicated in Section 3.3, all
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pixels in each sample, and obtained the number of lesion pixels Nles and the number of malignant
pixels Nmal as well. A sample will be classified as malignant if Nmal/Nles ≥ p, and therefore
the variance of this ratio amongst simulations must be as close to zero as possible in order for
this method to be valid. Variance in Nmal/Nles present among simulations was calculated and
plotted, per sample, in the right and center subplots of Fig. 10. This variance is worse, as
expected, between simulation runs with smaller reservoirs, although it remains well under 10−2
for reservoirs of size greater than 1000 in most samples. This, in turn, means that only a small
number of pixels per lesion are differently classified in different simulations, which empirically
demonstrates that both the PDF estimates provided by KDE and the defined diagnostic criterion
are resilient to changes in the reference population, as long as such population is sufficiently large
and accurately represents each pathology in feature space.



































Diagnosis variance - Malignant
Patient 56 samp. 0
Patient 61 samp. 0
Patient 66 samp. 0
Patient 71 samp. 0
Patient 76 samp. 0
Patient 81 samp. 0


















Diagnosis variance - Benign
Patient 86 samp. 0
Patient 116 samp. 0
Fig. 10. Consistency in PDF estimates with random reservoirs. Average variance of pixel
PDF values among machines of identical reservoir size (left subplot); per-sample variance
in diagnostic ratio among machines of identical reservoir size for malignant (center) and
benign lesions (right subplot). Probability density function and diagnosis variability are
generally negligible, but they are stabilized once reservoir size is in the order of 2000-3000
reference samples, meaning that these sizes provide sufficient statistically and clinically
significant information.
4. Conclusions
In this work, the ability of reservoir-basedKDE to segment and classify hyperspectral imageswhile
still correcting for interpatient and intersample variability has been described and empirically
tested, and a simple protocol inspired by the Neyman-Pearson lemma has been described. The
system can be configured to maximize accuracy, obtaining a nominal sensitivity, specificity and
accuracy of 96.8%, 95.7% and 96.0%, respectively, on a hyperspectral skin lesion dataset with
116 patients. It can also minimize false negative rates, obtaining a minimum false positive rate
of 9.5%. These statistics are either comparable or an improvement over other state-of-the-art
algorithms for spectral images of nevi [22, 25, 27, 31, 33, 38, 40], while its theoretical background
simplifies its usage, as it has but one degree of freedom in its operation.
In order to avoid complicating the clinical translation of this methodology, we seek to adapt
the method to the dermatologists’ needs. Modifying classification parameter γ1 provides for now
two modes of operation, which allows the algorithm to work in different scenarios:
• If we let γ1 take the optimal values of Table 2, that is, the value that maximizes accuracy for
our diagnostic criterion, we would be operating at optimal performance, at the maximum
true positive rate and minimum false negative rate that is achievable simultaneously.
• Finally, if we used γ1 as shown in Table 3, we would be operating in a zero-false-negative-
rate regime, which would perform in a greedier fashion, at the expense of not misdetecting
any melanomas.
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A notable difference is that, while classification results are well within those of state-of-the-art
machine learning systems, the procedure by which it takes place does not require training
per se. Instead, it estimates the probability distribution of each pathology in a feature space
obtained by reference data. No hidden function is calculated and no parameter learning takes
place. Segmentation threshold γ2 is obtained dynamically in each lesion to achieve automatic
segmentation and the malignant detection threshold parameter γ1 could be either ignored (γ1 = 1),
or set to the aforementioned ’maximum accuracy’ or ’minimum false negative rate’ operation
modes, which could be recalculated as new information arrives to the system.
It is fundamental to point also that this method could be used in other classification problems
with high dimensionality, even those presenting noise. As long as the magnitude of the noise does
not exceed significantly that of the features that differentiate classes among themselves –which
would make separability impossible in any case–, KDE would provide a smooth PDF estimate,
and classification by thresholding could be performed. Thus, applications of this algorithm
include, but are not limited to: on-line tissue segmentation during surgery; detection of the
presence of fluorescent markers and spurious artifacts; textural analysis and classification of
superficial lesions.
In a clinical setting, imaging a single lesion takes about 20-30 minutes. Learning and diagnosis
without methodology requires less than a minute (from milliseconds up to a second for the
diagnostic step, if the algorithm has been prepared in advance), which is acceptable in the
diagnosis of suspicious lesions [22]. Ideally, the rise of new modulated imaging systems that can
provide depth-resolved absorption and scattering information, such as those utilized recently in
melanocytic specimens [52], could also obtain with this method three-dimensional probability
maps of the hyperspectral voxels they are capable of measuring. That could provide surgically
relevant information in many subfields of oncological surgery, such as lumpectomy surgery
–e.g. providing the depth of the surgical margins in any lesion– and, in the field of dermatology,
provide an estimate of the Breslow depth of any skin lesion.
For now, given the exhibited high speed, accuracy, and segmentation capabilities of this
algorithm, the time required for proper diagnosis will be only limited by the imaging system,
and thus a first clinical trial could already take place, one in which the proposed methodology
is employed alongside already-existing MSI/HSI cameras and systems such as MelaFind [20],
providing a diagnostic assessment that minimizes false negatives and outputs the overall likelihood
of malignancy of any melanocytic lesion. This information could be used in secondary prevention,
and assist general practitioners and expert dermatologists in their mighty endeavor.
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